Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

PSMA PET imaging in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617: correlation with response, progression free (PFS) and overall survival (OS)

Muhammad Junaid Niaz, Michael Sun, Myrto Skafida, Ana Molina, John Babich, Shankar Vallabhajosula, David Nanus, Charlene Thomas, Paul Christos, Neil Bander, Scott Tagawa and Joseph Osborne
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 191;
Muhammad Junaid Niaz
1Urology Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Sun
2Medicine Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myrto Skafida
3Molecular Imaging and Theraputics Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Molina
2Medicine Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Babich
3Molecular Imaging and Theraputics Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shankar Vallabhajosula
1Urology Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Nanus
2Medicine Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlene Thomas
4Biostatistics and Epidemiology Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Christos
4Biostatistics and Epidemiology Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Bander
1Urology Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Tagawa
2Medicine Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Osborne
3Molecular Imaging and Theraputics Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 191

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Muhammad Junaid Niaz1,
  2. Michael Sun2,
  3. Myrto Skafida3,
  4. Ana Molina2,
  5. John Babich3,
  6. Shankar Vallabhajosula1,
  7. David Nanus2,
  8. Charlene Thomas4,
  9. Paul Christos4,
  10. Neil Bander1,
  11. Scott Tagawa2 and
  12. Joseph Osborne3
  1. 1Urology Weill Cornell Medical College New York NY United States
  2. 2Medicine Weill Cornell Medical College New York NY United States
  3. 3Molecular Imaging and Theraputics Weill Cornell Medical College New York NY United States
  4. 4Biostatistics and Epidemiology Weill Cornell Medical College New York NY United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to May 2025

AbstractFullPdf
May 20205200
Jun 20207900
Jul 20209900
Aug 20203800
Sep 20201500
Oct 20203600
Nov 20203800
Dec 20202600
Jan 20212400
Feb 20213500
Mar 20212200
Apr 20214200
May 20212900
Jun 20213200
Jul 20211400
Aug 20211900
Sep 2021600
Oct 20211600
Nov 2021700
Dec 20211000
Jan 20221100
Feb 2022900
Mar 20221100
Apr 20221300
May 20221000
Jun 2022600
Jul 2022600
Aug 2022400
Sep 2022400
Oct 2022400
Nov 20221400
Dec 2022900
Jan 2023700
Feb 2023600
Mar 2023700
Apr 2023700
May 2023100
Jun 2023600
Jul 2023200
Aug 20231200
Sep 2023400
Oct 2023200
Nov 2023400
Dec 2023800
Jan 2024700
Feb 2024400
Mar 2024500
Apr 2024600
May 2024400
Jun 20241100
Jul 2024400
Aug 20241300
Sep 2024600
Oct 2024600
Nov 2024600
Dec 2024700
Jan 2025400
Feb 2025700
Mar 2025400
Apr 20251200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PSMA PET imaging in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617: correlation with response, progression free (PFS) and overall survival (OS)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PSMA PET imaging in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617: correlation with response, progression free (PFS) and overall survival (OS)
Muhammad Junaid Niaz, Michael Sun, Myrto Skafida, Ana Molina, John Babich, Shankar Vallabhajosula, David Nanus, Charlene Thomas, Paul Christos, Neil Bander, Scott Tagawa, Joseph Osborne
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 191;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PSMA PET imaging in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617: correlation with response, progression free (PFS) and overall survival (OS)
Muhammad Junaid Niaz, Michael Sun, Myrto Skafida, Ana Molina, John Babich, Shankar Vallabhajosula, David Nanus, Charlene Thomas, Paul Christos, Neil Bander, Scott Tagawa, Joseph Osborne
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 191;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Prognostic value of tumor metabolic imaging phenotype using FDG PET radiomics in HNSCC
  • The value of 18F-FDG PET / MR in skull-base bone invasion of nasopharyngeal carcinoma
Show more Oncology: Clinical Therapy and Diagnosis

Prostate: PSMA PET and others

  • [90Y]Y-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer - Post-therapeutic kidney and bone marrow dosimetry for individualized therapy
  • Prostate 82Rb PET tumor blood flow measurement for detection of significant prostate cancer
Show more Prostate: PSMA PET and others

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire